Sentences with phrase «supplementary protection»

Her experience advising on commercial products means she regularly handles the complex interplay between patents, supplementary protection certificates and regulatory data protection.

The same legislation also provides for the granting of supplementary protection certificates (SPCs), which give additional patent protection of up to five years where there has been a regulatory delay in allowing patented medicines to be sold on the EU market.

One surprising gap in the EPO's information database covers the European Community's Supplementary Protection Certificate scheme, which is among the most significant patent developments of recent years in Europe.

Since Texas does not provide supplementary protections in these circumstances, workers are protected only by the WARN Act.

There was a short period of consultation on the Certificate of Supplementary Protection Regulations (link) and amendments to the Patented Medicines (Notice of Compliance) Regulations (link) at the end of July.

There are important filing deadlines for any application for a Certificate of Supplementary Protection based on both the grant of the underlying patent but also the timing of market approval in Canada and in other jurisdictions.

CETA Implementation: Guidance Documents and Notices Released to Address Amendments to the PM (NOC) Regulations and Certificate of Supplementary Protection for Pharmaceutical Patents

Alongside our patent attorneys who specialise in pharmaceutical chemistry, we have an experienced team working to obtain Supplementary Protection Certificates (SPCs).

Medical payments coverage is valuable supplementary protection that helps to fill out the totality of your auto and medical insurance coverage.

The legislation provided key reforms to the Patent Act affecting the pharmaceutical industry, including up to two years of patent term restoration for patented pharmaceuticals under the Certificate of Supplementary Protection Regulations (CSP).

He has extensive experience of patent prosecution in countries outside Europe and has pan-European expertise in the filing and prosecution of supplementary protection certificates nationally, as well as considerable experience and success before the European Court of Justice, including the widely cited Queensland (C - 630 / 10) and Neurim (C - 130 / 11) referrals.

On September 21, 2017, the Certificate of Supplementary Protection Regulations (CSP Regulations) came into force in Canada.

new NOC Regulations will also relate to infringement regarding a SPC that could result from «making, construction, use or sale of a patented invention or invention protected by a certificate of supplementary protection»

In parallel with the consultation on the Patent Rules, the CETA Implementation Act will also affect patents by introducing patent term extensions through certificates of supplementary protection (CSPs) for certain pharmaceutical inventions, and an overhauled the patent linkage system.

The Certificates of Supplementary Protection are available for both human use and veterinary use medicinal ingredients but as of this time, no applications have been filed for veterinary use.

See the Register of Certificates of Supplementary Protection (link) maintained by Health Canada for the latest status.

Franco has many years» experience throughout the world, in the Renewal of Patents of Invention, Designs, Utility Models, Supplementary Protection of Certificates, Textile Designs, Plant Varieties and Trademarks.

The term of the supplementary protection is a maximum of two years, based on the date that the authorization for sale set out in the certificate is issued but may be discounted by any «period of unjustified delay» caused by the applicant's failure to act.

Health Canada's online Register of Certificates of Supplementary Protection and Applications indicates that the first CSP has issued in relation to TrumenbaTM, a meningococcal group B vaccine.

It will also have competence over actions concerning infringement and validity of Supplementary Protection Certificates, for pharmaceutical and plant protection products, based on European bundle patents and unitary patents.

These CSPs are listed on Health Canada's new Register of Certificates of Supplementary Protection and Applications, along with a number of pending CSP applications.

Under the latter, Canada will, first, provide up to two years of supplementary protection to pharmaceutical patents due to delays in excess of five years between patent filing and market approval.

More specifically, CETA introduced a patent term extension of up to two years under the «certificates of supplementary protection» for regulatory delays and provided innovators with right of appeal under the Patented Medicines (Notice of Compliance) Regulations.

With the implementation of the CETA, as of September 21, 2017, Canadian law now provides for certificates of supplementary protection that extend the term of certain pharmaceutical patents for up to two years.

A maximum two years of additional patent rights for an approved drug will be available by a Supplementary Protection Certificate.

While a health plan typically covers the basic expense of cancer treatment, a cancer plan is a supplementary protection, designed to cover all costs of an expensive cancer treatment for all stages.